Arkolith/Insider Trading/KPTI/Form 4

Paulson Richard A.

President and CEO, DirectorKaryopharm Therapeutics Inc. (KPTI) · full profile →Form 4 · filed May 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$21K
Net Open-Market Flow
-$21K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 14, 2026Sell(S)2K$9.50$21K270K
May 13, 2026Grant(A)5K—$0272K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-226613) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML